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The target of rapamycin (TOR) kinase coordinately regulates fundamental metabolic and cellular processes to support
growth, proliferation, survival, and differentiation, and consequently it has been proposed as a therapeutic target for the
treatment of cancer, metabolic disease, and aging. The TOR kinase is found in two biochemically and functionally distinct
complexes, termed TORC1 and TORC2. Aided by the compound rapamycin, which specifically inhibits TORC1, the role of
TORC1 in regulating translation and cellular growth has been extensively studied. The physiological roles of TORC2 have
remained largely elusive due to the lack of pharmacological inhibitors and its genetic lethality in mammals. Among
potential targets of TORC2, the pro-survival kinase AKT has garnered much attention. Within the context of intact
animals, however, the physiological consequences of phosphorylation of AKT by TORC2 remain poorly understood. Here
we describe viable loss-of-function mutants in the Caenorhabditis elegans homolog of the TORC2-specific component,
Rictor (CeRictor). These mutants display a mild developmental delay and decreased body size, but have increased lipid
storage. These functions of CeRictor are not mediated through the regulation of AKT kinases or their major downstream
target, the insulin-regulated FOXO transcription factor DAF-16. We found that loss of sgk-1, a homolog of the serum- and
glucocorticoid-induced kinase, mimics the developmental, growth, and metabolic phenotypes of CeRictormutants, while
a novel, gain-of-function mutation in sgk-1 suppresses these phenotypes, indicating that SGK-1 is a mediator of CeRictor
activity. These findings identify new physiological roles for TORC2, mediated by SGK, in regulation of C. elegans lipid
accumulation and growth, and they challenge the notion that AKT is the primary effector of TORC2 function.
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Introduction
Target of rapamycin (TOR), a serine/threonine kinase of
the phosphatidylinositol kinase-related family, is broadly
conserved in eukaryotes, and in all systems examined, it is
required for normal growth [1]. The TOR kinase acts as a
sensitive cellular fuel gauge that receives inputs from multi-
ple growth-promoting signals and, in turn, orchestrates a vast
array of cellular responses such as translational control,
ribosome biogenesis, and autophagy [1]. TOR’s control of
these vital cellular processes makes it, on the organismal
scale, a critical player in numerous disease states, such as
cancer, aging, and cardiovascular disease [2].
One reason for the immense diversity of TOR-regulated
processes is that the kinase operates in two complexes, eachwith
its own unique set of components and subsequent substrates [3].
The proteins Raptor and Rictor (rapamycin-insensitive com-
panion of mTOR) are mutually-exclusive binding partners for
TORanddefine theTORC1andTORC2complexes, respectively
[3]. TORC1 can also be distinguished fromTORC2 functionally,
because only TORC1 is inhibited by the compound rapamycin
[3–5].Theuse of this drughas been themajordriving force in the
study of the TOR kinase—it enabled the identification of key
TORC1 targets [6–8], and the TOR kinase itself was first
discovered by genetic analysis in yeast aimed at determining
the mechanism of rapamycin’s growth-inhibitory action [9].
Deciphering physiological functions of TORC2 has been
hampered by lack of pharmacological inhibitors and lethality
of yeast and rodent Rictor mutants, although the development
of tissue-specific Rictor and Raptor knockout mice has recently
been reported [10–12]. While TOR- and Raptor-deficient
mouse embryos die soon after implantation, Rictor-deficient
embryos die in midgestation around embryonic day 10.5
(E10.5), suggesting that TORC2 is not required for early
proliferative and developmental events. Rictor knockout mice
are, at the time of embryonic arrest, slightly smaller and
developmentally delayed compared to wild-type littermates
[13,14]. The first viable Rictor mutant to be studied in any
organism was Pianissimo (Pia), the single Dictyostelium homolog.
These mutants are unable to activate adenylyl cyclase in
response to chemotactic GPCR signaling [15]. Viable Rictor
mutants have also recently been described in Drosophila
[16,17]. Consistent with the mouse data, reported phenotypes
of Drosophila Rictor mutants include a mild developmental
delay and an overall reduction in body size [16,17].
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Another source of complexity in understanding the
physiological roles of TORC2 is that, like any kinase, it has
multiple substrates. A seminal discovery in elucidating the
functions of TORC2 was its identification as a kinase
activator of AKT [18], which is a key mediator of signaling
of insulin and other pro-growth factor pathways and a kinase
that is inappropriately activated in numerous cancers [19].
AKT, like all related AGC family kinases, is phosphorylated at
several distinct sites, including the activation loop, mediated
by PDK1, and the C-terminal turn and hydrophobic motifs,
mediated by TORC2 [18,20,21]. Although hydrophobic motif
(HM) phosphorylation of AKT has become a major readout
for TORC2 function, it is not required for AKT to
phosphorylate many of its substrates [22]. As in mammals,
phosphorylation of the HM domain of Drosophila AKT is
severely reduced in Rictor-deficient flies [16,17], yet AKT
functions remain largely intact [16]. Similarly, removal of this
phosphorylation site from the Drosophila AKT does not
prevent its capacity to restore normal growth to tissues
lacking AKT [16]. Thus, while HM motif phosphorylation of
AKT increases its kinase activity in vitro [23] and has been
postulated to permit maximal levels of kinase activity in vivo
[16], the physiological significance of AKT as an effector of
TORC2 in intact animals has been difficult to assess. Other
AGC family kinases, such as PKC and SGK (serum- and
glucocorticoid-regulated kinase), contain the conserved HM
motif and have been proposed to mediate in vivo functions of
TORC2 in yeast [24,25], yet the interplay of TORC2 and its
various potential effectors in animals remain poorly under-
stood.
Another complicating factor in elucidating the physiolog-
ical functions of TORC2 is that genetic analyses of TORC2 in
mammalian cell culture and in intact animals have yielded
differing results. For instance, siRNA-induced knockdown of
Rictor in mammalian cells disrupts the actin cytoskeleton [26],
but ablation of Rictor through homologous recombination
causes lethality without notable effects on the actin cytoske-
leton [13,14]. Together, these observations raise the need for
disentangling the TOR signaling network within the context
of intact animals, where contributions of various potential
effectors of TORC2 on size, growth, and other potential
physiological processes can be rigorously examined.
Here, we report the identification of viable, loss-of-
function Rictor mutants in C. elegans. In addition to these
mutants having body size and growth defects, similar to
previous reports of Rictor mutants in other organisms [16], we
demonstrate that they also show an increase in stored fat. Our
genetic analyses of these mutants indicate that TORC2
regulates the observed fat storage, size, and developmental
phenotypes through sgk-1, rather than the AKTs. These
findings reveal that the SGK kinase family is a key
physiological mediator of the pro-growth and lipid storage
effects of TORC2.
Results
Identification of C. elegans Rictor Mutants
In a screen aimed at identifying C. elegans mutants with
altered lipid storage, we isolated lpo-6 (mg360), an allele of the
single C. elegans homolog of TORC2-specific component Rictor
(encoded by the gene F29C12.3). C. elegans stores fat in
intestinal and skin-like hypodermal cells, and intestinal stores
are readily detectable using the vital dye Nile Red [27].
Mutants identified in this screen were termed ‘‘lpo,’’ or
lipophilic dye abnormal. The lpo-6(mg360) mutation results in
a single amino acid substitution at a highly-conserved residue
in the C-terminal region of the protein, which has been
shown to be required for Rictor function in Saccharomyces
cerevisiae [28] (Figure S1). The excess fat accumulation of lpo-6
(mg360) mutants was associated with enlarged lipid-storing
subcellular particles throughout intestinal cells, as well as an
overall increase in Nile Red fluorescence (Figure 1A and 1B).
We confirmed increased lipid storage phenotype of lpo-6
(mg360) by staining with other lipid dyes—fatty acid-
conjugated BODIPY [27,29] and the fixed stain Sudan Black
[30] (Figure S2A and S2B). Overexpression of the wild-type,
genomic CeRictor locus in lpo-6 (mg360) mutants not only
reversed the increased fat phenotype of this mutant but
resulted in lower-than-wild-type fat levels (Figure 1C),
suggesting that the recessive mg360 mutation is a loss-of-
function allele. In addition to having excess fat, lpo-6 mutants
displayed decreased adult body size (Figure 1D) and a slight
developmental delay, phenotypes quite similar to those noted
in Drosophila Rictor mutants [16]. The decreased size and
developmental delay of lpo-6 (mg360) mutants were also
rescued to wild type by transgenic expression of the wild-
type genomic CeRictor locus (Figure 1E and unpublished data).
In an unrelated Nile Red screen, we later isolated another
allele of CeRictor, ft7, which is likely to be a null, as this
mutation results in a very early stop (Figure S1). Consistent
with this interpretation, the lpo-6 (ft7) mutation causes a
greater increase in fat storage, smaller body size, and a more
severe developmental delay than the lpo-6 (mg360) mutation
(Figure 1A, 1B, and 1D).
To compare lipid staining at matched developmental
stages, we allowed CeRictor mutants to grow for a longer
period of time than wild-type animals (see Materials and
Methods for details) so that we always assayed fat content at
the start of egg-laying in all strains. The increased fat staining
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Author Summary
The target of rapamycin (TOR) kinase acts as a conserved sensor of
energy status and governs diverse functions such as metabolism,
growth, and cell size via two separate multiprotein complexes. TOR
complex 1 (TORC1), which is sensitive to the immunosuppressant
drug rapamycin, is well understood but the physiological roles and
molecular mechanisms of action of the second TOR complex
(TORC2) are not so clear. We describe mutants in the single
Caenorhabditis elegans homolog of the gene Rictor, which is the
defining component of the TORC2 signaling complex. Mutant
worms are small, developmentally delayed, have reduced fecundity,
and store more fat than wild-type C. elegans does. Akt kinases, which
are pro-survival kinases that mediate the effects of insulin and other
growth factors, have been postulated to be key mediators of TORC2
signaling, as they are targets of TORC2 phosphorylation. We find,
however, that in C. elegans, TORC2 regulates fat storage, size, and
development entirely independent of the Akt kinases and of the
major target of insulin signaling, the FOXO-family transcription
factor DAF-16. Instead, we show genetically that TORC2 acts
through the activation of SGK-1, a kinase closely related to Akt, to
govern all three phenotypes. This work indicates a role for TORC2 in
fat regulation and shows that SGK-1 is a physiologically significant
mediator of TORC2 signaling.
of CeRictor mutants was not the result of this correction, as
animals grown for the same duration of time as wild type still
displayed increased fat staining even though they were less
mature (Figure S2C). The excess fat of CeRictor mutants was
not simply a reflection of the same total fat contained within
a smaller volume either. In fact, other similarly small-sized
mutants did not display enhanced fat accumulation (Figure
2C). Together, these findings indicate that CeRictor functions
to regulate fat storage, growth, and development.
CeRictor Mutant Phenotypes Are Mimicked by Loss of
Another TORC2 Component
While originally designated as a lethal gene inactivation,
the loss of CeTOR kinase encoded by let-363 allows for
completion of embryonic development but causes a non-
conditional larval-stage arrest with dauer-like phenotypes
[31,32]. Loss of daf-15/CeRaptor also results in dauer-like
developmental arrest [31,32]. By contrast, under identical
growth conditions, CeRictor mutants and wild-type animals
grow to reproductive adults without entry into the dauer
stage. We found that animals in which the C. elegans homolog
of lst-8 (encoded by C10H11.8) was targeted by RNAi also grew
to reproductive adults without dauer entry and, as adults,
displayed the fat, size, and developmental delay phenotypes
of CeRictor mutants (Figure S3 and unpublished data). lst-8
encodes for a G protein b subunit–like protein whose
mammalian homolog is found in both TORC1 and TORC2
complexes. Surprisingly, however, mLST-8 mutant mice dis-
Figure 1. Loss of CeRictor Causes Increased Lipid Storage and Decreased Body Size
(A) Images of Nile Red staining of lipids in anterior intestinal cells of adult wild-type, lpo-6 (mg360), and lpo-6 (ft7) strains. Representative images are
shown. In each image, anterior of the animal is to the right.
(B) Quantification of Nile Red staining. Mean fluorescence intensity is reported as a percentage of the mean for wild-type animals (error bars indicate
s.e.m.). Single asterisk indicates a p-value , 0.05, and double asterisk indicates p-value ,0.01 (wild type versus mutant, two-tailed t-test, n¼ 5–7).
(C) Quantification of Nile Red staining. Mean fluorescence intensity is reported as a percentage of the mean for wild-type animals (error bars indicate
s.e.m.). Single asterisk indicates a p-value  0.05, and double asterisk indicates p-value , 0.01 (wild type versus mutant, two-tailed t-test, n¼ 5–8). lpo-6
(þ) and (-) refer to the presence or absence of wild-type CeRictor transgene.
(D) Quantification of body size measurements. The perimeter of each worm was measured. Values reported as mean size as a percentage of mean for
wild type (error bars indicate s.e.m.). Double asterisk indicates p-value , 0.01 (wild type versus mutant strain, two-tailed t-test, n¼ 10).
(E) Quantification of body size measurements. The perimeter of each worm was measured. Values reported as mean size as a percentage of mean for
wild type (error bars indicate s.e.m.). Double asterisk indicates p-value , 0.01 (wild type versus mutant strain, two-tailed t-test, n¼ 10). lpo-6 (þ) and (-)
refer to the presence or absence of wild-type CeRictor transgene. Body size of rescued lpo-6 mutants (lpo-6 (mg360); lpo-6 (þ)) is not significantly
different from wild-type animals (p-value¼ 0.88, two-tailed t-test, n¼ 10).
doi:10.1371/journal.pbio.1000060.g001
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play the phenotypes of Rictor, not Raptor, mutants, and they
are not defective in the phosphorylation of known TORC1
targets [14]. Thus, our findings are consistent with murine
characterizations showing that Rictor mutant phenotypes are
recapitulated by inactivation of lst-8 while TOR mutant
phenotypes are recapitulated by Raptor inactivation. While
we are unable to rule out the possibility that RNAi may not
fully abrogate lst-8 expression, these data support the notion
that phenotypes associated with lpo-6 mutations are due to
reduced TORC2 signaling.
Expression Pattern of CeRictor
To determine the spatial relationship between Rictor and
other components of TOR complex, we examined the
expression pattern of a GFP reporter fusion controlled by
the rescuing promoter of CeRictor. GFP reporter fusions to let-
363/CeTOR and daf-15/CeRaptor are expressed throughout
development and adulthood in most tissues, including
intestine, skin-like hypodermis, pharyngeal and body wall
muscle, and the nervous system [31,32]. Expression of CeRictor
reporter fusion was limited to the intestinal and hypodermal
cells at early larval stages. As animals grew to the adult stage,
visible expression was restricted to the intestinal cells and a
single pharyngeal interneuron, I1 (Figure S1C–S1E). We do
not yet know the relevance of the observed I1 expression;
however, expression of the GFP reporter fusion in key fat-
storing tissues of C. elegans is consistent with a role for CeRictor
in regulating fat accumulation.
CeRictor Acts Independently of the DBL-1 TGF-b Pathway
to Regulate Body Size
Because Rictor mutants in both the fly and mouse display a
proportionate and subtle decrease in body size [13,16], we
chose to examine the mechanisms by which CeRictor regulates
size. Changes in either cell number or cell size may alter total
body size. The reduced body size of lpo-6 mutants, however, is
unlikely to be the result of a failure in cell proliferation, as
there are no obvious groups of cells missing or reduced in
number in lpo-6 mutants. These animals only show a size
defect after they complete larval development (unpublished
data). Together with the fact that the C. elegans cell lineage is
highly invariant, these findings suggest that the small size of
CeRictor mutant reflects a defect in achieving post-mitotic cell
size.
The major size-regulatory pathway in C. elegans is mediated
by a TGF-b ligand, DBL-1, that connects signaling upstream
in the nervous system to the skin-like hypodermal cells and
modulates cell size throughout the organism in a dose-
dependent manner [33]. Size regulatory egl-4, dbl-1, sma-6, and
lon-1 define a linear genetic pathway (Figure 2A). The EGL-4
cGMP-dependent protein kinase is required for mediating
food-related sensory cues that elicit diverse behavioral and
physiological responses [34]; it also acts in sensory neurons to
regulate body size [35]. Gain-of-function mutations in egl-4
[e.g., egl-4 (ad450)], cause a decrease in size, whereas loss-of-
function mutations [e.g., egl-4 (n478)] result in increased size
[35,36]. The large size of loss-of-function egl-4 mutants is fully
suppressed by loss of dbl-1 [35]. The DBL-1 ligand is produced
in the neurons of the nerve cord that extends the length of
the animal, and it signals through the SMA-6 and DAF-4 TGF-
b receptors acting in the hypodermis to promote normal size
[37,38]. In turn, the SMA-6/DAF-4 receptors regulate the
transcription of numerous genes that specifically influence
cell growth; one such target is LON-1, a protein of
uncharacterized biochemical function whose transcription
is repressed by DBL-1 and SMA-6. Loss-of-function mutations
in lon-1 increase body size and suppress the small size of dbl-1
and sma-6 mutants [39,40].
We probed the relationship between CeRictor signaling and
this previously-characterized size pathway by constructing
double mutant strains bearing the lpo-6 (mg360) mutation and
other size-altering mutations. The lpo-6 (mg360) mutation
decreased body size in nearly all backgrounds examined
Figure 2. CeRictor Regulates Size Independent of the dbl-1 Pathway
(A) Genetic regulatory hierarchy of the dbl-1-mediated body size
pathway. Molecular function, expression pattern, and representation of
null phenotype for each component are indicated.
(B) Quantification of body size measurements. The perimeter of each
worm was measured. Sizes are reported as percentage of wild type (error
bars indicate s.e.m). For each gene, sizes of both mutant strain alone
(black bars) and mutant strain also harboring the lpo-6 (mg360) mutation
(gray bars) are shown. Asterisks indicate significance of difference
between single mutant and lpo-6 (mg360);mutant strain; single asterisk
indicates p-value , 0.05 and double asterisk indicates p-value , 0.01
(two-tailed t-test, n¼ 10–20 per strain). sma-6 (wk7) and sma-6 (wk7);lpo-
6 (mg360) are not significantly different (two-tailed t-test, p ¼ 0.24).
Percentages above bars represent the percent reduction in lpo-6
(mg360); mutant strain as compared to mutant strain alone (percentage
refers to size as a percentage of wild type).
(C) Quantification of Nile Red staining. Mean fluorescence intensity is
reported as a percentage of the mean for wild-type animals (error bars
indicate s.e.m.). For each gene, sizes of both mutant strain alone (black
bars) and mutant strain also harboring the lpo-6 (mg360) mutation (gray
bars) are shown. Asterisks indicate significance of difference between
single mutant and lpo-6 (mg360); mutant strain; single asterisk indicates
p-value , 0.05, and double asterisk indicates p-value , 0.01 (two-tailed
t-test, n ¼ 5–7 per strain). As indicated in Materials and Methods, the
reported values for fat correspond to Nile Red fluorescence within the
first three pairs of intestinal cells without adjustment for differences in
cell size between mutants.
doi:10.1371/journal.pbio.1000060.g002
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(Figure 2B). Several observations indicated that CeRictor
cannot be placed within a linear genetic relationship with
other size-regulatory pathway components. First, the small-
sized lpo-6 (mg360) mutant was not fully suppressed by size-
increasing egl-4 and lon-1 mutations, nor did it fully suppress
the effects of these mutations (Figure 2B). Second, loss of
CeRictor had a much greater effect in normal-sized or large
strains, compared to small-sized strains (Figure 2B). For
example, loss of CeRictor reduced the size of lon-1 mutants by
nearly 20%, whereas it reduced the size of dbl-1 or sma-6
mutants by only 3–5%, a 4- to 6-fold difference. Thus, rather
than CeRictor acting as a component of the size-regulatory dbl-
1 pathway, these epistatic relationships indicate that CeRictor
has a permissive function acting in parallel with the dbl-1
pathway to shape the final organismal form. In support of this
hypothesis, the lpo-6 (mg360) mutation resulted in increased
lipid staining in every size-altering background, suggesting
that CeRictor does not act through the DBL-1 pathway (Figure
2C).
The excess fat storage and genetic relationship of CeRictor
mutants with other size-pathway mutants suggested that
CeRictor may influence organismal size by regulating the
utilization of resources toward energetic processes like cell
growth and development. As such, because of an increased
demand for resources, mutants that display excessive cell size
(such as the lon-1 and egl-4 loss-of-function mutants) would be
more dependent upon growth-permissive TORC2 signaling
than mutants with modest size.
CeRictor Mutants Display Wild Type Feeding Behavior but
Decreased Fecundity
To further characterize the role of CeRictor in energy
balance, we examined whether CeRictor activity is also
necessary to promote other energetically demanding pro-
cesses. CeRictor mutants had grossly normal rates and
patterns of locomotion (unpublished data). By contrast,
these animals produced ;40% fewer progeny than wild
type, resulting in over 100 fewer offspring on average
(Figure 3A). We also examined food intake behavior of
CeRictor mutants by measuring the pharyngeal pumping rate
[41]. The more severe feeding-defective (eat) mutants share
some phenotypes with CeRictor mutants—decreased size,
slow growth, and reduced brood size [41]. Unlike the eat
mutants, however, the pumping rate of lpo-6 (mg360) animals
was indistinguishable from that of wild-type animals under
well-fed conditions (Figure 3B), suggesting that the in-
creased lipid storage of CeRictor mutants is not attributable
to feeding behavior and that their pleiotropic phenotypes
are not simply due to insufficient nutrient intake at the level
of feeding. Our findings suggest that TORC2 activity
promotes body size, development, and progeny production
in a regulated fashion, consistent with the known role of
TOR kinase as a gauge of nutrient availability that
coordinates utilization of energetic resources. Moreover,
the severity of phenotypes caused by loss of CeRaptor relative
to those caused by CeRictor indicate that the TOR kinase can
fine tune responses of the organism to environmental
conditions.
CeRictor Regulation of Lipid Storage, Size, or Development
Is Independent of AKT and DAF-16/FOXO Signaling
To investigate the molecular mechanisms through which
CeRictor regulates fat storage, size, and development, we first
focused on Akt and insulin signaling. AKT phosphorylation at
the HM site by TORC2 has been hypothesized to be a major
output of TORC2 [18,22], and the Akt/insulin signaling
pathway is a major regulator of metabolism and growth
[42]. C. elegans has two AKT homologs that act redundantly to
phosphorylate the FOXO transcription factor, DAF-16, which
is a key effector of responses elicited upon reduced insulin
signaling [43]. Inactivation of the daf-2 insulin receptor or
simultaneous inactivation of both Akt genes results in dauer
arrest that is fully suppressed by mutation of daf-16 [43]. If
CeRictor acts solely through activation of the Akt genes to
inhibit DAF-16/FOXO, then null mutations in daf-16 should
suppress all CeRictor mutant phenotypes. Strikingly, we found
that elimination of daf-16/FOXO did not alter the lipid
storage, body size, nor developmental phenotypes of CeRictor
mutants (Figure 4A–4D). These results show that CeRictor acts
in parallel to or downstream of daf-16 in regulation of size,
rate of development, and fat accumulation.
Next, we explored the possibility that CeRictor functions
through the Akt pathway but independent of its DAF-16
output. To avoid dauer arrest caused by inactivation of both
Akt genes and to specifically investigate daf-16-independent
outputs of Akt signaling, we asked whether akt-1; akt-2; daf-16
triple mutants mimicked any of the phenotypes seen in
CeRictor mutants. These triple mutants accumulated nearly
wild-type fat levels (Figure 4A and 4B), exhibited slightly
elevated body size (Figure 4C), and displayed a very mild
developmental delay (Figure 4D). Moreover, the quadruple
lpo-6 (mg360); akt-1; akt-2; daf-16mutant strain was no different
with respect to fat storage or body size than lpo-6 (mg360)
alone (Figure 4A–4C). These results show that the excess fat
and reduced size of CeRictor mutant are unlikely to be
consequences of reduced AKT activity, because complete
removal of AKT activity does not mimic or alter these
phenotypes. Furthermore, we found that the loss of CeRictor
in the context of akt-1, akt-2, and daf-16 mutations resulted in
a synthetic reduction in developmental rate (Figure 4D),
Figure 3. Inactivation of CeRictor Does Not Affect Feeding Rate but Is
Required for Normal Reproduction
(A) Total number of progeny was counted for individual wild-type or lpo-
6 (mg360) animals (n¼ 10 per strain). Average brood sizes are expressed
as a percentage of wild type (error bars indicate s.e.m.). Double asterisk
indicates p-value , 0.01(two-tailed t-test).
(B) Feeding rate (pharyngeal pumping) was measured in lpo-6 (mg360)
and wild-type animals (n¼ 20 for each strain). Average rate is expressed
as a percentage of wild type (error bars indicate s.e.m.). Strains were
measured as well-fed adults. Wild-type and lpo-6 (mg360) animals are not
significantly different (p¼ 0.14, two-tailed t-test).
doi:10.1371/journal.pbio.1000060.g003
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delaying the onset of egg-laying by nearly 24 h relative to wild
type [compared to a roughly 6-h delay in lpo-6 (mg360) alone].
This again suggests that the growth delay of CeRictor mutants
is not merely a reflection of reduced AKT activity but that
CeRictor acts in parallel to a novel, daf-16–independent Akt
signaling pathway to regulate development. These results do
not exclude the possibility that CeRictor may activate Akt for
other physiological processes or under other conditions, but
they strongly indicate that the fat, size, and developmental
phenotypes of CeRictor are not consequences of compromised
AKT signaling.
CeRictor Acts in a Pathway with sgk-1 to Regulate Lipid
Storage, Size, and Development
Since the AKTs and DAF-16/FOXO were not the relevant
outputs for CeRictor with respect fat, size, and developmental
rate, we investigated the possibility of TORC2 regulation of
these processes through other AGC family kinases. Knockdown
of the three C. elegans PKC homologs resulted in visible
phenotypes, but not those associated with CeRictor mutants
(unpublished data). Strikingly, however, targeting the single
SGK homolog, sgk-1, by RNAi resulted in fat, size, and
developmental phenotypes strongly resembling CeRictor mu-
Figure 4. CeRictor Regulation of Lipid Storage, Size, and Development Is Independent of Akt and FOXO Function
(A) Images of Nile Red staining of lipids in anterior intestinal cells.
(B) Quantification of Nile Red staining. Mean fluorescence intensity is reported as a percentage of the mean for wild-type animals (error bars indicate
s.e.m.). Asterisk indicates p-value , 0.05 (wild type versus mutant, two-tailed t-test, n¼ 4–5). lpo-6 (mg360);daf-16 and lpo-6 (mg360);akt-1;akt-2;daf-16
are not significantly different from lpo-6 (mg360) (two-tailed t-tests, p-values for both comparisons are 0.44).
(C) Quantification of body size. Values are reported as mean size as a percentage of mean for wild type (error bars indicate s.e.m.). Double asterisk
indicates p-value , 0.01 (wild type versus mutant strain, two-tailed t-test, n ¼ 10). lpo-6 (mg360);daf-16 and lpo-6 (mg360);akt-1;akt-2;daf-16 are not
significantly different from lpo-6 (mg360) (two-tailed t-test, p-values are 0.84 and 0.12, respectively).
(D) Developmental timing of mutant strains. Animals were grown from synchronized L1s for 72 h at 20 8C; individuals were then scored for
developmental stage. Fifty nine–156 animals were used for each strain.
doi:10.1371/journal.pbio.1000060.g004
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tants (unpublished data). We confirmed these RNAi phenotypes
by using an sgk-1mutant likely to be a null, because a deletion in
this strain removes most of the region encoding the SGK-1
kinase domain [44]. sgk-1 null mutants displayed a fat accumu-
lation phenotype very similar to that of lpo-6 (ft7) (the likely null
allele of CeRictor), both in terms of enlarged lipid particle
morphology (Figure 5A) and total fluorescence (Figure 5B). As
previously reported [44], sgk-1mutants had decreased size and a
slight developmental delay, and these phenotypes were highly
similar to those of lpo-6 (ft7) animals (Figure 5C and 5D).
Both CeRictor and sgk-1 are expressed in the intestinal cells,
raising the possibility of a direct regulatory connection [44].
To ascertain whether CeRictor and sgk-1 define a singular
pathway, we examined the phenotypes of lpo-6; sgk-1 double
mutants. Although each null allele on its own had robust Nile
Red, size, and developmental phenotypes, the double mutant
showed no enhancement of any of the three phenotypes
when compared with sgk-1 alone (Figure 5A–5D), demon-
strating that lpo-6 and sgk-1 act in the same pathway to
regulate these processes. Consistent with CeRictor’s daf-16–
Figure 5. CeRictor and sgk-1 Define a Single Regulatory Pathway Governing Fat Storage, Body Size, and Developmental Rate
(A) Images of Nile Red staining of lipids in anterior intestinal cells.
(B) Quantification of Nile Red staining. Mean fluorescence intensity is reported as a percentage of the mean for wild-type animals (error bars indicate
s.e.m.). Single asterisk indicates p-value , 0.05, and double asterisk indicates p-value , 0.01 (wild type versus mutant, two-tailed t-test, n¼ 5–6). lpo-6
(ft7) is not significantly different from sgk-1 (two-tailed t-test, p-value¼ 0.20). sgk-1 does not statistically differ from sgk-1;lpo-6 (ft7) or sgk-1;daf-16 (two-
tailed t-tests, p-values¼ 0.63 and 0.81, respectively).
(C) Quantification of body size. Values reported as mean size as a percentage of mean for wild type (error bars indicate s.e.m.). Double asterisk indicates
p-value, 0.01 (wild type versus mutant strain, two-tailed t-test, n¼10). sgk-1 does not statistically differ from sgk-1;lpo-6 (ft7) or sgk-1;daf-16 (two-tailed
t-tests, p-values¼ 0.11 and 0.14, respectively).
(D) Developmental timing of mutant strains. Animals were grown from synchronized L1s for 72 h at 20 8C; individuals were then scored for
developmental stage. Sixty–185 animals were used for each strain.
doi:10.1371/journal.pbio.1000060.g005
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independent function, we found that the complete loss of
daf-16 did not suppress or otherwise alter the fat, size, and
developmental delay phenotypes of sgk-1 mutants (Figure
5A–5D). All previously described phenotypes of sgk-1
inactivation in C. elegans (increased tendency for dauer
formation when combined with other mutations, enhanced
stress resistance, and extended lifespan) had been shown to
operate entirely through the inhibition of DAF-16/FOXO
[44]. Thus, our findings indicate that additional mediators of
SGK function remain to be identified. Finally, sgk-1 mutants
also exhibited the same synthetic developmental delay
phenotype in the context of the akt-1; akt-2; daf-16 triple
mutants (Figure 6A) that we observed with lpo-6 (mg360)
mutants (Figure 4D). Taken together, our genetic results
indicate that CeRictor and sgk-1 function in a shared pathway
to regulate fat storage, size, and development. These results
are consistent with findings in S. cerevisiae, where the TORC2
complex has been shown to directly phosphorylate the SGK
Figure 6. A Gain-of-Function Mutation in sgk-1 Suppresses the Fat Storage, Body Size, and Developmental Phenotypes of lpo-6 (mg360)
(A) Developmental timing of mutant strains. Animals were grown from synchronized L1s for 72 h at 20 8C; individuals were then scored for
developmental stage. Sixty–185 animals were used for each strain. One hundred and six–181 animals were used for each strain. In all panels of this
figure, sgk-1 (gf) refers to the described sgk-1 (ft15) allele, and sgk-1 refers to the null deletion allele, sgk-1 (ok538).
(B) Images of Nile Red staining of lipids in anterior intestinal cells.
(C) Quantification of Nile Red staining. Mean fluorescence intensity is reported as a percentage of the mean for wild type or vector control (error bars
indicate s.e.m.). Asterisk indicates p-value , 0.05 (lpo-6 (mg360);sgk-1 (gf) grown on vector control versus sgk-1 RNAi, or lpo-6 (mg360) grown on vector
control versus lpo-6 (mg360);sgk-1 (gf) grown on vector control, two-tailed t-test, n¼ 5–6). sgk-1 grown on vector control does not differ significantly
from sgk-1 grown on sgk-1 RNAi (two-tailed t-test, p-value¼ 0.77).
(D) Quantification of body size. Values reported as mean size as a percentage of mean for wild type on vector control (error bars indicate s.e.m.). Double
asterisk indicates p-value , 0.01 (lpo-6 (mg360);sgk-1 (gf) grown on vector control versus sgk-1 RNAi, or lpo-6 (mg360) grown on vector control versus
lpo-6 (mg360);sgk-1 (gf) grown on vector control, two-tailed t-test, n¼ 10). sgk-1 grown on vector control does not differ significantly from sgk-1 grown
on sgk-1 RNAi (two-tailed t-test, p-value¼ 0.89).
doi:10.1371/journal.pbio.1000060.g006
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homolog Ypk2 to regulate growth and ceramide synthesis
[24,25].
A Novel, Gain-of-Function Mutation in sgk-1 Suppresses
the Lipid Storage, Size, and Developmental Phenotypes of
CeRictor
To demonstrate that CeRictor regulates lipid metabolism
and growth by activating sgk-1, we first attempted to generate
a constitutively active form of SGK-1. We reasoned that such
an activated SGK-1 would rescue phenotypes caused by loss
of CeRictor. We speculated that substitutions of glutamic acid
or aspartic acid for the threonine at residue 444 in the HM
domain of CeSGK-1, equivalent to S422 in mouse SGK-1,
might result in a constitutively active SGK-1. We generated
SGK-1 constructs with a glutamic acid substitution at Thr444
alone and aspartic acid substitutions simultaneously at
Thr444 and the predicted phosphorylated residue within
the turn motif. The introduction of these transgenes into
CeRictor mutants did not, however, result in rescue of any of
the phenotypes of these mutants (unpublished data). The
structural and biochemical reasons why these amino acid
substitutions failed to generate activated SGK-1 are not
known, but these results are similar to what has been
reported in S. cerevisiae. In that system, substituting aspartic
acid residues at both the hydrophobic motif and turn motif
phosphorylation sites on Ypk2 also fails to rescue tor2
mutants [25].
Next, we undertook an unbiased, forward mutagenesis
screen aimed at identifying suppressors of CeRictor. To isolate
specific suppressors of CeRictor, we mutagenized lpo-6 (mg360);
akt-1; akt-2; daf-16 animals and screened the F2 generation for
those that suppress this strain’s developmental delay. As a
secondary screen, we then searched for suppressors that also
abrogate the increased Nile Red phenotype of the quadruple
mutant strain. Reasoning that an activating mutation in sgk-1
might suppress CeRictor, we sequenced the sgk-1 locus in all
potential mutants that passed both rounds of screening and
identified one line with a mutation in sgk-1. This allele, sgk-1
(ft15), has a G-to-A transition resulting in a Glu-to-Lys amino
acid substitution at residue 116, shortly before the start of the
kinase domain (Figure S4A and S4B). The sgk-1 (ft15)
mutation partially suppresses the synthetic developmental
delay of the lpo-6; akt-1; akt-2; daf-16 strain (Figure 6A), and
exposure of lpo-6; akt-1; akt-2; daf-16; sgk-1 (ft15) quintuple
mutants to sgk-1 RNAi abrogated the effects of the ft15 allele,
suggesting that this allele is likely a gain-of-function mutation
in sgk-1 (unpublished data).
To determine its effect on CeRictor alone, we outcrossed the
sgk-1(ft15) mutation, removing the akt-1 and daf-16 mutations
in the background; however, because sgk-1 is linked to the akt-
2 locus, the outcrossed ft15 mutant strain also retained the
akt-2 deletion, which we have shown does not suppress any of
the phenotypes of lpo-6 (mg360) (Figure 4A–4D). sgk-1 (ft15)
mutants displayed wild-type body size and fat, and the
mutation completely suppressed both the decreased body
size and increased fat phenotypes of lpo-6 (mg360) mutants
(Figure 6B–6D). The ft15 allele also suppressed the slight
developmental delay of the lpo-6 (mg360) single-mutant strain
(unpublished data). Finally, the sgk-1 (ft15) mutation was
inherited in a semi-dominant manner, and inactivation of sgk-
1 by RNAi abolished the ability of sgk-1 (ft15) to suppress lpo-6
(mg360) phenotypes (Figure 6C and 6D). Interestingly, sgk-1
(ft15) is a weaker suppressor of the more severe, null CeRictor
allele, lpo-6 (ft7); in this background, it partially suppresses the
small size phenotype and does not significantly reduce fat
staining (Figure S4C and S4D). We do not currently know the
biochemical consequences of the mutation caused by ft15 on
SGK-1 activity. Similarly, additional studies are needed to
elucidate how SGK-1 activity is specifically affected by the
partial or total loss of CeRictor function. Nevertheless, these
genetic results strongly indicate that the ft15 allele produces
an activating mutation in SGK-1 and that this mutation
suppresses nearly all of the phenotypes associated with
CeRictor, demonstrating conclusively that CeRictor signals
through sgk-1 to regulate lipid storage, size, and development.
In sum, the observations that loss-of-function mutations in
sgk-1 mimic phenotypes of CeRictor, while a forward genetic
screen aimed at finding suppressors of CeRictor identified an
sgk-1 gain-of-function mutation, indicate that sgk-1 is a
physiologically significant mediator of TORC2 activity in C.
elegans.
Discussion
We have found that loss of Rictor function causes devel-
opmental delay, reduced size and reproduction, but excess fat
accumulation in C. elegans. Similar phenotypes have been
observed by another group using independently generated
alleles of Rictor (A. Soukas and G. Ruvkun, personal
communication). As inactivation of another core TORC2
component, LST-8, recapitulates the CeRictor phenotypes, our
findings suggest that, as in all other systems examined,
CeRictor functions as part of the TORC2 complex. We found
that the phenotypes caused by CeRictor inactivation were
independent of activities of AKT and its downstream
effector, the DAF-16/FOXO transcription factor. We further
found that all of the phenotypes associated with loss of
CeRictor were fully mimicked by loss of sgk-1 and that these
phenotypes were suppressed by a novel, gain-of-function
mutation in sgk-1. These data indicate that Rictor, through
TORC2, regulates fat storage, size, and development in C.
elegans, and it governs all three phenotypes through upstream
activation of sgk-1.
While the discovery that TORC2 phosphorylates AKT on
its HM motif has been critical in characterization of various
TORC2 complex components and identifying potential
TORC2 targets based on HM domain homologies, the most
prominent phenotypes caused by inactivation of TORC2 in C.
elegans are independent of this activity. CeRictor appears to act
through sgk-1 but in parallel to both Akt genes to promote
development, as the simultaneous loss of both Akt homologs
and CeRictor/sgk-1 results in a synergistic developmental delay.
This genetic interaction occurs in the absence of daf-16
activity, demonstrating FOXO-independent outputs for the
C. elegans Akts and sgk-1. Nevertheless, it is likely that, under
certain circumstances, C. elegans TORC2 would modulate
specific Akt functions. Indeed, the C. elegans AKT-1 protein
does contain a conserved, PDK2 consensus phosphorylation
site in its HM motif (unpublished data), suggesting that, as in
all other organisms tested thus far, C. elegans Akt is likely a
substrate of CeTORC2. In Drosophila, the only physiological
role attributable to HM motif phosphorylation of AKT is
modulation of insulin signaling specifically when the activity
of the insulin pathway is abnormally enhanced, either by
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overexpression of FOXO transcription factor or inactivation
of PTEN, a phosphatase that elevates PIP3 levels and thus
enhances AKT activity [16]. Consistent with our findings,
under normal growth conditions, abrogation of AKT’s HM
domain phosphorylation has minimal effects on AKT-
dependent cell growth in Drosophila [16].
The TORC2-SGK regulatory pathway is conserved across
phylogeny and is used for a variety of physiological processes.
In S. cerevisiae, TORC2 regulates ceramide synthesis through
activation of YPK2 (an SGK homolog in S. cerevisiae), which in
turn is required for membrane synthesis and active cell
growth [24]. Gain-of-function mutations in YPK2 suppress
the lethality of TORC2 loss-of-function mutations [25], just as
the ft15 gain-of-function mutation in sgk-1 suppresses the
metabolic and growth phenotypes of CeRictor. Interestingly, in
Dictyostelium, TORC2 is required to activate both the closest
Akt and Sgk homologs, and both kinases regulate cell growth
and chemotaxis [45]. In mammals, the regulation of SGK
family kinases by mTORC2 and its physiological significance
are just beginning to be probed. Recently, mTORC2 has been
shown to be required for mSGK1 hydrophobic motif
phosphorylation in mammalian cells, and immunoprecipi-
tated mTORC2 directly phosphorylates mSGK1 in vitro [46].
Furthermore, phosphorylation of an SGK1-specific target is
reduced in cells deficient in mTORC2 components [46]. Thus,
SGK appears to be the predominant effector of TORC2
under normal growth conditions in S. cerevisiae and C. elegans,
and a similar regulatory interaction is suggested by in vitro
and cell-based studies in mammalian systems.
Whether TORC2 and SGK kinase family regulate fat
metabolism in mammals is not yet known. A muscle-specific
deficiency of Rictor has recently been reported, and Rictor
seems to be largely dispensable for proper muscle cell
morphology, function, and respiration [10]. While an adi-
pose-specific knockout of Raptor has been described, a similar
knockout of Rictor has not [11]. Whereas the C. elegans genome
contains a single SGK gene, mammals have three. Sgk1 and
Sgk3 knockout mice have surprisingly mild phenotypes,
possibly due to redundant functions of SGKs. Sgk2-null mice
have not yet been reported. Sgk3-null mice display a transient
growth delay and defects in hair follicle development,
whereas Sgk1-null mice are defective in salt balance under a
salt-deficient diet and their glucose uptake by various tissues
post glucose load is blunted [47,48]. The deep evolutionary
origins of numerous mammalian and C. elegans fat regulatory
pathways suggest that in mammals, as in C. elegans, mTORC2
and mSGK family of kinases may also play roles in lipid
metabolism; likewise, it will be important to demonstrate
whether mTORC2 activation is required for any of the
processes known to be governed by the mSGKs, such as
sodium transport and blood pressure regulation.
Materials and Methods
C. elegans strains and maintenance. Nematodes were grown
according to standard protocols at 20 8C [49]. N2 Bristol was used
as wild-type strain. The following strains were used: daf-16 (mgDf47) I,
daf-16 (mgDf47) I;lpo-6 (mg360) II, daf-16 (mgDf47) I;lpo-6 (mg360) II;akt-1
(mg306) V;akt-2 (tm812) X, daf-16 (mgDf47) I;lpo-6 (mg360) II;akt-1
(mg306) V;akt-2 (tm812);sgk-1 (ft15) X, daf-16 (mgDf47) I;akt-1 (mg306)
V;akt-2 (tm812) X, daf-16 (mgDf47) I;akt-1 (mg306) V;akt-2 (tm812);sgk-1
(ok538) X, daf-16 (mgDf47) I;sgk-1 (ok538) X, sma-6 (wk7) II, sma-6 (wk7)
II;lpo-6 (mg360) II, lpo-6 (mg360) II, lpo-6 (mg360) II;lon-1 (e185) III, lpo-6
(mg360) II;egl-4 (ad450sd) IV, lpo-6 (m,g360) II;egl-4 (n478) IV, lpo-6
(mg360) II;dbl-1 (nk3) V, lpo-6 (ft7) II, lpo-6 (mg360) II;akt-2 (tm812);sgk-1
(ft15) X, lpo-6 (ft7) II;akt-2 (tm812);sgk-1 (ft15) X, lpo-6 (ft7);sgk-1 (ok538)
X, lpo-6 (mg360);ftEx560[Plpo-6::lpo-6genomic::polycis-GFP; Pmyo-2::mCherry],
lon-1 (e185) III, egl-4 (ad450sd) IV, egl-4 (n478) IV, dbl-1 (nk3) V, akt-2
(tm812);sgk-1 (ft15) X, sgk-1 (ok538) X, N2;ftEx645[Plpo-6::GFP; Podr-1::RFP].
Lipid staining. Nile Red staining and image analysis were
performed as described previously [50,51]. Briefly, images were taken
with identical exposure times and below saturation of pixel intensity.
The first three pairs of anterior intestinal cells were selected (we
previously demonstrated that this is generally representative of fat
content quantification that includes the entire animal). Using ImageJ
software, Nile Red–stained particles were enhanced by the Spot-
Tracker Gaussian filter, a mask was created to remove background
signal, and fluorescence intensity was measured. For all experiments,
worms were synchronized by hypochlorite treatment of adults and
imaged at the onset of egg-laying. All comparisons were conducted on
animals that were at the same developmental stage. Due to the delay
in developmental rate, strains containing lpo-6 (mg360) were imaged
4–6-h later than wild type, strains containing lpo-6 (ft7) or sgk-1 were
imaged 9–10 h later than wild type, and lpo-6 (mg360);akt-1;akt-2;daf-16
worms were imaged ;20 h later than wild type. Because of
suppression of the developmental delay phenotype of lpo-6 (mg360),
the lpo-6 (mg360);sgk-1 (ft15) was plated at the same time as sgk-1 (ft15)
and wild type. C. elegans were stained with BODIPY 500/510 C1,C12 in
the same manner as that described for Nile Red, but the concen-
tration was different: 1mg/ml BODIPY in DMSO stock was diluted
1:2,500 then 0.5 ml were added to 6-cm NGM plates seeded with
OP50. Sudan Black staining was performed as described previously
[50]. Representative images from single experiments are shown; each
experiment was repeated on variably numerous occasions but at least
twice. In each experiment 5–10 animals were quantified per
genotype.
Body size measurements. Images of adult worms were taken at 53
magnification, and perimeter was traced and measured using Open-
lab software (Improvision). Pixel measurements were converted to
microns by calibration using a stage micrometer. Animals were
measured at the onset of egg-laying; developmental timing differ-
ences were adjusted as described above. Single experiments are
shown—each experiment was performed at least twice, and in each
experiment 10–20 animals were measured per genotype.
RNAi. RNAi by feeding was performed as described previously
[52]. RNAi clone against C10H11.8 (lst-8 homolog) from the Ahringer
feeding library was used [53]. RNAi was induced for two generations
(synchronized adults were grown from L1s on HT115 expressing
RNAi or L4440, then eggs harvested by hypochlorite treatment).
Synchronized progeny were plated on RNAi plates with Nile Red and
analyzed as adults. For sgk-1 RNAi experiments, the RNAi clone
against W10G6.2 (sgk-1) from the Vidal feeding library was used [54].
In these experiments, RNAi was induced for one generation, starting
as synchronized L1s.
Rescue and promoter::GFP reporter constructs. Entire genomic
locus for lpo-6 (F29C12.3) plus 1,039 base pairs of upstream sequence
was amplified in three PCR fragments overlapping by 1 kb. The last
fragment contained a polycistronic sequence fused to GFP and the
unc-54 39 UTR (gift of G. Brown) by PCR fusion. All three fragments
were injected at 10 ng/ll into the gonad of lpo-6 (mg360) adults. For
expression pattern, rescuing promoter was amplified by PCR, cloned
into Gateway vector (Invitrogen), and fused in-frame to GFP with the
unc-54 39 UTR. Plasmid was injected into N2 animals at 100 ng/ll with
Podr-1::RFP as a coinjection marker.
Feeding rate measurements. Experiments were performed essen-
tially as described previously [50]. Egg-laying adults were measured in
each experiment; strains were adjusted for developmental differences
as indicated above.
Mutagenesis screening. Ethyl methanesulfonate mutagenesis was
performed as described previously [49]. Mutagenesis was carried out
in two batches, totaling approximately 60,000 F1s and 300,000 F2s. For
each batch, mutagenized lpo-6 (mg360); akt-1; akt-2; daf-16 animals were
allowed to grow to adulthood, and their progeny were collected by
sodium hypochlorite treatment in eight separate pools. These were
allowed to grow to adulthood, whereupon their progeny were
collected in the same manner. Synchronized F2s were then allowed
to grow for approximately 72 h at 20 8C (because of their
developmental phenotype, lpo-6 (mg360); akt-1; akt-2; daf-16 animals
grown as described were an asynchronous mix of animals, none of
which was older than very early L4 stage) then screened for the rare
young or gravid adult animals. Potential suppressor lines were then
retested on plates containing Nile Red, and only those whose
developmental suppression was reproducible and further suppressed
PLoS Biology | www.plosbiology.org March 2009 | Volume 7 | Issue 3 | e10000600613
CeRictor Signals through sgk-1
the increased staining of the original lpo-6 (mg360); akt-1; akt-2; daf-16
strain were selected for future study.
Supporting Information
Figure S1. Molecular Cloning of CeRictor Mutants
(A) Gene structure for lpo-6 (F29C12.3). Intron/exon boundaries are
shown to scale. Below is a schematic of the LPO-6 protein; numbers
reflect amino acid sequence of LPO-6 protein (there are no consensus
domains in the protein as predicted by sequence homology). Sites and
consequences of both mg360 and ft7 mutations are shown.
(B) Multiple-species alignment of conserved, C-terminal region where
mg360 allele substitution is found. Asterisk denotes the mutated
residue.
(C) Expression pattern of rescuing lpo-6 promoter fused to GFP in
adult animal. Note exclusively intestinal expression pattern, with the
exception of I1 interneuron. Image results from merge of fluores-
cence and DIC channels.
(D) Expression pattern of rescuing lpo-6 promoter fused to GFP in
early larval animal. Note both intestinal (I) and hypodermal (H)
expression. Image results from merge of fluorescence and DIC
channels.
(E) Expression of rescuing lpo-6 promoter fused to GFP in I1
interneuron. Image results from merge of fluorescence and DIC
channels. Neuron was identified as I1 due to the position of the cell
body and a projection crossing the pharynx and extending anterior
on the side opposite the cell body.
Found at doi:10.1371/journal.pbio.1000060.sg001 (3.26 MB PDF).
Figure S2. Increased-Fat Phenotype of CeRictor Mutants Is Confirmed
by Other Lipid Staining Methods and Is Not Due to Developmental
Timing
(A) Images of fatty acid-conjugated BODIPY staining in adult wild
type, lpo-6 (mg360) and lpo-6 (ft7) strains. Representative images are
shown.
(B) Images of Sudan Black B staining in wild type, lpo-6 (mg360) and
lpo-6 (ft7) strains. Sudan Black staining is generally less sensitive than
Nile Red and Bodipy-conjugated fatty acids in detecting fat stores.
Because of the variability of Sudan Black staining, we previously
devised a protocol [50] allowing for pairwise comparison between
strains stained within the same tube. Thus, representative images of
wild-type and test animals from each experiment are shown.
(C) Comparison of fat accumulation as detected by Nile Red staining
in sgk-1 and CeRictor mutants. All strains were allowed to grow for the
same amount of time after synchronized hatching by hypochlorite
treatment of parents. Differences in developmental timing were not
corrected. Mean fluorescence intensity is reported as a percentage of
the mean for wild-type animals (error bars indicate s.e.m.). Asterisk
indicates p-value ,0.05 (wild type versus mutant, two-tailed t-test, n¼
5–6).
Found at doi:10.1371/journal.pbio.1000060.sg002 (845 KB PDF).
Figure S3. Two-Generation lst-8 RNAi Results in Fat and Size
Phenotypes Similar to CeRictor Mutants
(A) Representative images of control- and RNAi-treated animals
(adult stage) stained with Nile Red. Note an increase in fluorescence
intensity and an increase in lipid particle size, similar to what was
noted with lpo-6 mutants.
(B) Quantification of body size. RNAi value reported as mean size as a
percentage of mean for control treatment (error bars indicate s.e.m.).
Double asterisk indicates p-value ,0.01 (control versus RNAi, two-
tailed t-test, n ¼ 10). Note that body size of RNAi-treated animals is
nearly identical to that of lpo-6 (ft7) mutants (see also Figure 1D).
Found at doi:10.1371/journal.pbio.1000060.sg003 (714 KB PDF).
Figure S4. Molecular Cloning of sgk-1 (ft15) and Epistasis Analyses
with lpo-6 (ft7)
(A) Schematic representation of CeSGK-1, showing to scale its
conserved domains, putative phosphorylation sites (TM¼ turn motif
and HM¼ hydrophobic motif), and location and consequence of ft15
mutation.
(B) Multiple-species alignment of conserved region where ft15 allele
substitution is found. Asterisk denotes the mutated residue.
(C) Quantification of body size. Values reported as mean size as a
percentage of mean for wild-type animals (error bars indicate s.e.m.).
Double asterisk indicates p-value ,0.01 (wild type versus mutant
strain or lpo-6 (ft7) vs. lpo-6 (ft7);sgk-1 (gf), two-tailed t-test, n ¼ 10). In
all panels, sgk-1 (gf) refers to the sgk-1 (ft15) allele.
(D) Quantification of Nile Red staining. Mean fluorescence intensity
is reported as a percentage of the mean for wild-type animals (error
bars indicate s.e.m.). Double asterisk indicates p-value ,0.01 (wild
type versus mutant, two-tailed t-test, n¼ 5–8). lpo-6 (ft7);sgk-1 (gf) does
not differ significantly from lpo-6 (ft7) or sgk-1 (gf) (p-values¼ 0.39 and
0.07, respectively).
Found at doi:10.1371/journal.pbio.1000060.sg004 (817 KB PDF).
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